1591 - 1600 of 6509 Results
Title
Year
-
OPENTitle: Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression AnalysisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2016.00046Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2016.00046/pdfCitation Count: 35
- Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease2016OPENTitle: Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1012End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26621Best OA location URL: http://doi.org/10.1002/mds.26621Citation Count: 35
-
OPENTitle: Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 64Issue #: 3Start Page: 995End Page: 1007Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-180088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6082178Citation Count: 20
-
OPENTitle: Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 128Issue #: 2Start Page: 605End Page: 616Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2016.11.jns161162Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/128/2/article-p605.pdfCitation Count: 132
-
OPENTitle: Network correlates of the cognitive response to levodopa in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 858End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c6224Best OA location URL: https://n.neurology.org/content/neurology/77/9/858.full.pdfCitation Count: 64
-
OPENTitle: Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed weldersJournal Name: Occupational and Environmental MedicinePublisher: BMJVol: 69Issue #: 6Start Page: 437End Page: 443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/oemed-2011-100119Best OA location URL: https://oem.bmj.com/content/oemed/69/6/437.full.pdfCitation Count: 108
-
OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 32
-
OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2016.03.002Citation Count: 79
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Citation Count: 26
-
OPENTitle: Glial scars are permeable to the neurotoxic environment of chronic stroke infarctsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 63End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.007Best OA location URL: https://doi.org/10.1016/j.nbd.2018.01.007Citation Count: 113